Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11351232 Albumin-free botulinum toxin formulations
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 21 Jun, 2023
"update inverses"
Golden AI
edited on 21 Jun, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11680087 None
0
Edits on 24 Apr, 2023
"Entity importer update"
Golden AI
edited on 24 Apr, 2023
Infobox
Is a
Patent
0
Patent Applicant
Revance Therapeutics, Inc.
0
Current Assignee
Revance Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11351232
0
Date of Patent
June 7, 2022
0
Patent Application Number
16175434
0
Date Filed
October 30, 2018
0
Patent Citations
US Patent 10080786 Methods for treating pain by topical application and transdermal delivery of botulinum toxin
0
US Patent 10105421 Therapeutic composition with a botulinum neurotoxin
0
US Patent 10111939 Albumin-free botulinum toxin formulations
0
US Patent 10172877 Compositions and methods for topical diagnostic and therapeutic transport
0
US Patent 10201594 Compositions and methods for safe treatment of rhinitis
0
US Patent 10285941 Amphiphilic entity nanoparticles
0
US Patent 10549042 Botulinum toxin prefilled glass syringe
0
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
0
US Patent 10576034 Botulinum nanoemulsions
0
US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins
0
Patent Primary Examiner
Nita M. Minnifield
0
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 4 Apr, 2023
Infobox
Patent Citations
US Patent 10172877 Compositions and methods for topical diagnostic and therapeutic transport
0
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 29 Mar, 2023
Infobox
Patent Citations
US Patent 10080786 Methods for treating pain by topical application and transdermal delivery of botulinum toxin
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 26 Mar, 2023
Infobox
Patent Citations
US Patent 10105421 Therapeutic composition with a botulinum neurotoxin
0
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 23 Mar, 2023
Infobox
Patent Citations
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
0
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 28 Sep, 2022
Infobox
Patent Citations
US Patent 10080786 Methods for treating pain by topical application and transdermal delivery of botulinum toxin
0
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 28 Sep, 2022
Infobox
Patent Citations
US Patent 10172877 Compositions and methods for topical diagnostic and therapeutic transport
0
"update citations for inverse infoboxes"
Golden AI
edited on 28 Sep, 2022
Infobox
Patent Citations
US Patent 10111939 Albumin-free botulinum toxin formulations
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
0
Patent Applicant
Revance Therapeutics, Inc.
0
Current Assignee
Revance Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11351232
0
Date of Patent
June 7, 2022
0
Patent Application Number
16175434
0
Date Filed
October 30, 2018
0
Patent Citations
US Patent 10080786 Methods for treating pain by topical application and transdermal delivery of botulinum toxin
0
US Patent 10105421 Therapeutic composition with a botulinum neurotoxin
0
US Patent 10111939 Albumin-free botulinum toxin formulations
0
US Patent 10172877 Compositions and methods for topical diagnostic and therapeutic transport
0
US Patent 10201594 Compositions and methods for safe treatment of rhinitis
0
US Patent 10285941 Amphiphilic entity nanoparticles
0
US Patent 10549042 Botulinum toxin prefilled glass syringe
0
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
0
US Patent 10576034 Botulinum nanoemulsions
0
US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins
0
Patent Primary Examiner
Nita M. Minnifield
0
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10549042 Botulinum toxin prefilled glass syringe
0
Edits on 9 Jun, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 9 Jun, 2022
Edits made to:
Infobox
(
+19
properties)
Article
(
+26
characters)
US Patent 11351232 Albumin-free botulinum toxin formulations
Article
This invention relates to
Infobox
Is a
Patent
Patent applicant
Revance Therapeutics, Inc.
Current assignee
Revance Therapeutics, Inc.
Patent jurisdiction
United States Patent and Trademark Office
Patent number
11351232
Date of patent
June 7, 2022
Patent application number
16175434
Date Filed
October 30, 2018
Patent citations
US Patent 10080786 Methods for treating pain by topical application and transdermal delivery of botulinum toxin
US Patent 10105421 Therapeutic composition with a botulinum neurotoxin
US Patent 10111939 Albumin-free botulinum toxin formulations
US Patent 10172877 Compositions and methods for topical diagnostic and therapeutic transport
US Patent 10201594 Compositions and methods for safe treatment of rhinitis
US Patent 10285941 Amphiphilic entity nanoparticles
US Patent 10549042 Botulinum toxin prefilled glass syringe
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
US Patent 10576034 Botulinum nanoemulsions
US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins
Patent primary examiner
Nita M. Minnifield
Find more entities like US Patent 11351232 Albumin-free botulinum toxin formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE